Key result
NOACs effectively prevent AF stroke and catheter ablation offers durable rhythm control for paroxysmal cases.
Why the study?
Atrial fibrillation is associated with increased risks of mortality, heart failure, and stroke, necessitating effective management strategies including anticoagulation and ablation.
This review summarizes the principles of oral anticoagulant therapy and catheter ablation approaches for the management of atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Supports NOAC and ablation strategies in AF; leaves open need for updated primary trials in diverse populations.
Atrial fibrillation (AF) is associated with increases in the risk of mortality, congestive heart failure, and stroke. Medical treatment is aimed at preventing thrombo-embolic complications and reducing symptoms and consequences related to the arrhythmia. In the first section of this review, we discuss the principles of mainstream oral anticoagulant therapy and the possible advantages of the new oral anticoagulants. In the second section, we review the catheter ablation approaches to paroxysmal and persistent/long-standing AF, their results, and the current application of new catheters.
No takes yet. Share an insight, caveat, or question.
Vergara et al. (2014) conducted a review in Atrial fibrillation. Anticoagulation and catheter ablation was evaluated. New oral anticoagulants provide effective stroke prevention in atrial fibrillation, and catheter ablation offers a durable rhythm control strategy, particularly for paroxysmal cases.
Synapse has enriched 10 related papers. Consider them for comparative context: